Belgium vs Iraq: Patent applications, residents
Patent applications, residents over time
- Belgium
- Iraq
How they compare
Belgium currently reports 647 against 556 in Iraq, a difference of 91.
That makes Belgium's figure about 1.2 times Iraq's.
The two have swapped places 2 times across 24 shared years of data; in 1980 it was Belgium ahead.
Belgium ranks 40th and Iraq ranks 42nd of 139 countries.
Belgium has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Belgium | Iraq | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 768.9 | 153.5 | 615.4 | Belgium |
| 1990s | 747.2 | 113.8 | 633.4 | Belgium |
| 2010s | 929.5 | 584.5 | 345 | Belgium |
| 2020s | 740 | 668.4 | 71.6 | Belgium |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher patent applications, residents, Belgium or Iraq?
- Belgium, at 647 against 556 in Iraq as of 2024.
- What is the difference in patent applications, residents between Belgium and Iraq?
- 91, with Belgium ahead.
- How many years of comparable data are there for Belgium and Iraq?
- 24 years are reported by both, from 1980 to 2024.
- How do Belgium and Iraq rank globally for patent applications, residents?
- Belgium ranks 40th and Iraq ranks 42nd of 139 countries.
- Where does this data come from?
- WIPO Patent Report: Statistics on Worldwide Patent Activity, World Intellectual Property Organization (WIPO), note: The International Bureau of WIPO assumes no responsibility with respect to the trans, published as Patent applications, residents. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Patent applications are worldwide patent applications filed through the Patent Cooperation Treaty procedure or with a national patent office for exclusive rights for an invention--a product or process that provides a new way of doing something or offers a new technical solution to a problem. A patent provides protection for the invention to the owner of the patent for a limited period, generally 20 years.